What are the societal impacts of rapid advances in the life science sector?

Ulrike Gnad-Vogt talks us through CureVac’s efforts to target seasonal influenza

As the world continues to take on the post-COVID flu epidemic, we ask RQ Bio CEO Hugo Fry what part monoclonal antibodies play in new flu treatments

Gene Sullivan, Chief Product Strategy Officer at Insmed, explores how new thinking could improve the research process for rare disease treatments

Groups of tiny glass frogs can sleep on a leaf in daylight and go entirely undetected by predators

UICC CEO Cary Adams gives his insights into the challenges of getting cancer treatment to people in low- and middle-income countries.

MIT scientists believe the future is bright for antibiotics discovery

Who do we blame for the return of polio?

Genentech goes beyond pharmaceutical manufacturing in its work with members of the SMA community. Michael Dunn explains

For any organization, one ill-timed tweet can create enormous backlash.